ATE516031T1 - Verbindungen gegen krebs - Google Patents

Verbindungen gegen krebs

Info

Publication number
ATE516031T1
ATE516031T1 AT03808232T AT03808232T ATE516031T1 AT E516031 T1 ATE516031 T1 AT E516031T1 AT 03808232 T AT03808232 T AT 03808232T AT 03808232 T AT03808232 T AT 03808232T AT E516031 T1 ATE516031 T1 AT E516031T1
Authority
AT
Austria
Prior art keywords
sub
against cancer
compounds against
formula
compounds
Prior art date
Application number
AT03808232T
Other languages
English (en)
Inventor
Qian Shi
Hui-Kang Wang
Masayoshi Oyama
John Vance
Ming Chen
Original Assignee
Androscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Androscience Corp filed Critical Androscience Corp
Application granted granted Critical
Publication of ATE516031T1 publication Critical patent/ATE516031T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03808232T 2002-10-11 2003-10-14 Verbindungen gegen krebs ATE516031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41778502P 2002-10-11 2002-10-11
PCT/US2003/032547 WO2004033423A2 (en) 2002-10-11 2003-10-14 Anticancer compounds

Publications (1)

Publication Number Publication Date
ATE516031T1 true ATE516031T1 (de) 2011-07-15

Family

ID=32094089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03808232T ATE516031T1 (de) 2002-10-11 2003-10-14 Verbindungen gegen krebs

Country Status (9)

Country Link
US (1) US6903133B2 (de)
EP (1) EP1610790B1 (de)
JP (1) JP4707393B2 (de)
AT (1) ATE516031T1 (de)
AU (1) AU2003300385A1 (de)
CA (1) CA2501901A1 (de)
HK (1) HK1085675A1 (de)
TW (1) TWI307341B (de)
WO (1) WO2004033423A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0206206A (pt) * 2001-10-26 2005-01-11 Centre Nat Rech Scient Derivados de etoposide e análogos, e composições farmacêuticas contendo os mesmos
WO2007052808A1 (ja) * 2005-11-07 2007-05-10 Nissan Chemical Industries, Ltd. ヒドラジド化合物及びトロンボポエチンレセプター活性化剤
WO2008136018A2 (en) * 2007-05-03 2008-11-13 Council Of Scientific & Industrial Research 4beta-amin0 podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof
WO2010052733A1 (en) * 2008-11-07 2010-05-14 Council Of Scientific & Industrial Research NOVEL 4β-AMINO PODOPHVLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF
CN102757443B (zh) * 2011-04-27 2014-10-29 汤亚杰 硫取代鬼臼类衍生物及其生物转化和分离纯化方法
CN102757442B (zh) * 2011-04-27 2015-06-24 汤亚杰 硫取代鬼臼类衍生物及其合成方法和应用
CN102432622B (zh) * 2011-11-16 2014-07-23 常州大学 4-胺基噁二唑表鬼臼毒素衍生物及其制备方法和用途
CN102603761B (zh) * 2012-02-02 2013-12-25 华东师范大学 含有异羟肟酸结构的表鬼臼毒化合物及制备方法和用途
CN103613600B (zh) * 2013-11-15 2017-01-04 湖北工业大学 具抗肿瘤活性的苯胺基鬼臼类衍生物及其制备方法和用途
CN103601732A (zh) * 2013-11-15 2014-02-26 湖北工业大学 具抗肿瘤活性的氮取代鬼臼类衍生物及其制备方法和用途
CN103613601B (zh) * 2013-11-15 2017-01-11 湖北工业大学 硫取代鬼臼毒素类衍生物及其合成方法和应用
CN103804388B (zh) * 2014-01-29 2016-03-23 中国医学科学院药用植物研究所 4β-氮取代呋喃叔胺类鬼臼毒素衍生物及其制备方法与应用
CN108285455B (zh) 2017-08-16 2022-02-08 汤亚杰 4β-氨基取代鬼臼毒素类衍生物及其制备方法和应用
CN108285456B (zh) 2017-09-22 2022-02-08 汤亚杰 4-硫取代鬼臼毒素类衍生物及其制备方法和应用
CN116332950A (zh) * 2023-03-20 2023-06-27 汤亚杰 一种吲唑取代鬼臼毒素类衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02191279A (ja) * 1988-10-26 1990-07-27 Warner Lambert Co ４‐ブロモ‐４′‐デメチルエピポドフイロトキシンおよびその新規な誘導体の製法
US5061791A (en) 1988-12-21 1991-10-29 Warner-Lambert Company 4-bromo-4'-demethylepipodophyllotoxin derivatives
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
US5132322A (en) 1989-02-23 1992-07-21 The University Of North Carolina At Chapel Hill Etoposide analogues
JPH0343802A (ja) * 1989-07-12 1991-02-25 Omron Corp ファジィコントローラ
US5332811A (en) 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW221441B (de) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
US5338867A (en) 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
FR2739857B1 (fr) * 1995-10-12 1998-01-02 Pf Medicament Nouveaux derives amines de 2",3"-didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
US6207673B1 (en) * 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
US6051721A (en) 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
US6441198B1 (en) 2000-12-22 2002-08-27 Council Of Scientific And Industrial Research Podophyllotoxin dimer as DNA topoisomerase II inhibitors, and a process for the preparation therefore

Also Published As

Publication number Publication date
AU2003300385A1 (en) 2004-05-04
TWI307341B (en) 2009-03-11
EP1610790A2 (de) 2006-01-04
JP4707393B2 (ja) 2011-06-22
WO2004033423A3 (en) 2004-07-29
US6903133B2 (en) 2005-06-07
JP2006503079A (ja) 2006-01-26
TW200410959A (en) 2004-07-01
CA2501901A1 (en) 2004-04-22
WO2004033423A2 (en) 2004-04-22
EP1610790A4 (de) 2009-03-25
US20040138288A1 (en) 2004-07-15
HK1085675A1 (en) 2006-09-01
AU2003300385A8 (en) 2004-05-04
EP1610790B1 (de) 2011-07-13

Similar Documents

Publication Publication Date Title
HK1085675A1 (en) Anticancer compounds
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
ATE433447T1 (de) Pyrimiidinverbindungen
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20041493L (no) Kjemiske forbindelser.
ATE338461T1 (de) Pyrazolpyrimidinfungizide
WO2007106192A3 (en) Inhibitors of iap
CY1105386T1 (el) Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου
MXPA05012268A (es) N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
DK1385515T3 (da) Spiropyrazole forbindelser
MXPA05012837A (es) Inhibidores de caspasa y usos de los mismos.
ATE413388T1 (de) Muskarin antagonisten
MXPA04006041A (es) Antivirales de piridoquinoxalina.
ATE498600T1 (de) Inden derivate als pharmazeutika
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
EA200600607A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы
ATE359283T1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
CY1105345T1 (el) Φαινυλαλκινια
ATE431328T1 (de) Photopolymerisierbare verbindungen
DE60202669D1 (de) 6-phenylbenzonaphthyidine
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
MXPA06000372A (es) Compuestos de silicio y su uso.
EA200600609A1 (ru) Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties